-- Syntara（ASX：SNT）周二向澳大利亚证券交易所提交的文件显示，在一次C类会议上，美国食品药品监督管理局（FDA）给予了积极反馈，支持其针对骨髓纤维化治疗药物amsulostat的2b期临床试验方案设计。 该文件指出，该2b期临床试验的主要终点是治疗9个月后总症状评分降低50%，预计将招募约100名患者。 该公司表示，美国FDA的积极反馈使得amsulostat得以进入后期临床开发阶段，并为与潜在商业伙伴的进一步合作铺平了道路。 骨髓纤维化是一种骨髓癌，其特征是瘢痕组织的积聚导致红细胞、白细胞和血小板减少。
Related Articles
Treasury
Commerzbank on Overnight News
Commerzbank in its "European Sunrise" note of Tuesday highlighted:Markets: United States Treasuries and German Bunds stay on the back foot. Japanese government bond curve flattens from both sides after the Bank of Japan rate decision, with odds for June hike lifted above 70%. S&P closes at a new record and e-minis stay supported, Nikkei falls. Brent rises above US$109/barrel. The euro (EUR) weakens, yen (JPY) rallies.Iran war: President Donald Trump is reviewing the Iran proposal and will address the matter "very soon," says White House spokeswoman. NYT reports Trump is "dissatisfied" with the proposal, WSJ says he is "wary." Secretary of State Marco Rubio says Iran's offer is better than expected, but questioned whether the person who submitted it had the authority to do so. Rubio also said Iran wants control of the Strait of Hormuz, which is unacceptable.U.S.: International carmakers threaten to pull cheapest models from the U.S. without a trade deal (WSJ).==EUROPE:Germany: The finance ministry is preparing several options to deal with budget widening, including debt brake exemption on the emergency clause (Bloomberg).U.K.: British BRC shop prices fell to 1% year over year in April from 1.2%, consensus was looking for an increase to 1.4%.==ASIA:Japan: The BoJ keeps rates on hold in a 6-3 vote, core inflation forecast for this year was raised to 2.8%.
$$CXY$$EUR$$JPY
Asia
TDK's Profit Climbs 17% in Fiscal Year Ended March
TDK's (TYO:6762) profit attributable to owners of the parent rose 17% to 195.7 billion yen for the fiscal year ended March 31 from 167.2 billion yen a year earlier.The electronics company's earnings per share increased to 102.97 yen from 87.98 yen a year ago, according to a Tokyo bourse filing on Tuesday.Net sales jumped 14% to 2.505 trillion yen from 2.205 trillion yen in the prior year.In a separate disclosure, TDK raised its final dividend payout to 20 yen per share from 18 yen initially planned, and is payable from June 22.For the fiscal year ending March 31, 2027, the company expects attributable profit of 225 billion yen, basic EPS of 118.54 yen, and net sales of 2.58 trillion yen.TDK plans to pay interim and year-end dividends of 20 yen per share, each, for the year, which is higher than the amount paid in the year-ago period.
$TYO:6762
Equities
Capital One Adjusts Price Target on EQT to $68 From $64, Maintains Overweight Rating
EQT (EQT) has an average rating of overweight and mean price target of $70.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$EQT